An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug ...

By obtaining high-resolution images of Alzheimer’s disease-affected brain cells as the condition progresses, researchers have identified the specific neurons that are damaged. The information the ...

New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction ...

NHS patients are set to miss out on new Alzheimer’s disease drugs, experts warn.Earlier this year lecanemab, the first ...

New details have emerged into how Alzheimer’s disease affects the brain. Researchers have identified cellular changes in the brains of people with the disease — and a timeline of when they occur.

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new ...

Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping ...

For decades, scientists have focused on beta-amyloid plaques as the primary cause of Alzheimer's disease. These protein ...

Researchers discovered that two genetic variants, APOE4 and TREM2 R47H, increase Alzheimer's disease risk by triggering ...

As the need for new Alzheimer's treatments grows, the market will become more crowded for pharma companies and segmentation will become an ever more useful tool in market research, drug ...